Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ATHE compared with CELU: revenue, margins and what each company keeps, and the suppliers and customers both name
ATHE
Alterity Therapeutics Ltd
Change
Mkt cap
Revenue
Revenue
CELU
Celularity Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ATHE
Alterity Therapeutics Ltd
vs
CELU
Celularity Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ATHE
5
—
JonesTrading Institutional Services
unlisted
supplier
—
PricewaterhouseCoopers
unlisted
supplier
—
The Bank of New York Mellon (BNYM)
unlisted
supplier
—
The University of Melbourne's Bio21 Molecular Science and Biotechnology Institute
unlisted
supplier
1 more · ATHE chain
›
Shared
0
No disclosed counterparties: CELU.
Only CELU
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
ATHE
Alterity Therapeutics Ltd
Change
2.43
▲
+9.46%
· post 2.43
Mkt cap
$804,783
Revenue
—
CELU
Celularity Inc
Change
0.84
▲
+15.73%
· post 0.76
Closed
Nov 6 '26
Mkt cap
$23.5M
Revenue
$4M
Q1 FY26
vs
Compare
Closed
Nov 6 '26
ATHE
Alterity Therapeutics Ltd
vs
CELU
Celularity Inc
2.43
▲
+9.46%
post 2.43
Price
0.84
▲
+15.73%
post 0.76
$804,783
Mkt cap
$23.5M
—
Revenue
$4M
Q1 FY26
Change
Change
ATHE
2.43
▲
+9.46%
vs
CELU
0.84
▲
+15.73%
Closed
Nov 6 '26